A Type II Segmental Vitiligo Developed Under Infliximab Treatment for Ulcerative Colitis

Annals of Dermatology - South Korea
doi 10.5021/ad.2017.29.6.826
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Korean Dermatological Association and The Korean Society for Investigative Dermatology (KAMJE)

Related search

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Treatment for Ulcerative Colitis

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2010English

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

Gastroenterology
HepatologyGastroenterology
2009English

Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands

Biologics in Therapy
2012English

Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis

Cost Effectiveness and Resource Allocation
Health Policy
2009English

Treatment of Ulcerative Colitis

JAMA - Journal of the American Medical Association
Medicine
1959English

Treatment of Ulcerative Colitis

BMJ
1966English

Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy